In-hospital management and disposition outcomes for patients with mild traumatic brain injury and isolated traumatic subarachnoid hemorrhage

When a person suffers a blow to the head, doctors often look for bleeding inside the skull. This bleeding, known as a traumatic brain injury, can take several forms depending on where the blood collects and how much pressure it creates. In many cases, the injury is classified as "mild" if the patient remains awake and alert, scoring high on a standard scale used to measure consciousness. For decades, medical practice has leaned toward caution: if a scan shows any bleeding, patients are typically admitted to the hospital for observation. The logic is simple and protective. Doctors want to catch any sudden worsening of the injury before it becomes dangerous, often ordering repeat scans to ensure the bleeding is not expanding. However, this cautious approach comes with a cost. It fills hospital beds, keeps people away from their homes, and consumes significant medical resources, even for injuries that might never get worse.

A team of researchers in Denmark recently set out to examine whether this blanket policy of admission and repeated scanning is necessary for a specific group of patients. They focused on individuals with mild brain injuries who had only one specific type of bleeding: a small amount of blood in the space surrounding the brain, known as a traumatic subarachnoid hemorrhage. The question was whether these patients fared differently than those with other types of bleeding, such as clots pressing against the brain's surface or bleeding within the brain tissue itself. By looking at real-world records from a single hospital, the researchers hoped to see if the outcomes for the subarachnoid group were so safe that they could be managed differently, perhaps allowing them to go home sooner without the need for extra scans or specialized rehabilitation.

The study reviewed the records of 127 patients admitted to a neurosurgery department between April 2022 and the end of 2024. All of these individuals had suffered a mild brain injury and were found to have bleeding on their initial brain scans. The researchers divided them into two main groups for comparison. The first group consisted of 69 patients whose scans showed only the isolated subarachnoid bleeding. The second group, which the researchers called the "pooled" group, included the remaining 58 patients who had other types of bleeding, such as epidural hematomas, subdural hematomas, or bleeding within the brain tissue, either alone or mixed together. The team then tracked what happened to these patients during their hospital stay. They looked at how long each person stayed in the hospital, whether they needed a second brain scan, if they required surgery, and whether they were sent to a rehabilitation center upon leaving the hospital.

The results painted a clear picture of two different paths. The patients with only the isolated subarachnoid bleeding had a much smoother course. On average, they stayed in the hospital for just two days. In contrast, the patients with the other types of bleeding stayed for an average of 3.2 days. The difference was even more pronounced in how often they needed repeat scans. Only about two-thirds of the isolated bleeding group required a second scan, whereas nearly 85 percent of the other group did. Perhaps most significantly, the need for rehabilitation was far lower for the isolated group. Only 10 percent of those with just the subarachnoid bleeding were sent to inpatient rehabilitation, compared to 26 percent of the others. When the researchers adjusted their calculations to account for factors like age, overall health, and whether patients were taking blood-thinning medications, the pattern held true. Patients with the other types of bleeding were more than twice as likely to be discharged to a rehabilitation facility compared to those with the isolated subarachnoid bleeding.

The study also addressed a common concern: whether taking blood-thinning medication, such as aspirin or stronger anticoagulants, made the isolated bleeding more dangerous. In this group of patients, those taking antiplatelet drugs like aspirin did not show an increased risk of needing rehabilitation or repeat scans compared to those not taking such medication. However, the picture was slightly different for those on stronger anticoagulants, who did appear to have a higher risk of needing further care, though the numbers for this specific subgroup were small. Crucially, no patient in the isolated subarachnoid group required neurosurgical intervention, such as surgery to drain fluid or relieve pressure. Two patients in the other group did require surgery, and two others from that group were readmitted to the hospital with seizures within a month of their initial discharge.

The authors emphasize that while these findings are compelling, they come with important caveats. The study was conducted at a single hospital and relied on looking back at past records, which means the results are not a final proof but rather a strong suggestion for how things might work. The researchers noted that their hospital has specific protocols where all patients with brain bleeding are admitted to the neurosurgery unit, which might not reflect how other hospitals operate. They also pointed out that they could not perfectly distinguish between different sizes of the subarachnoid bleeding based on the radiology reports available. Despite these limitations, the data suggests that for patients with mild brain injuries and only this specific type of bleeding, the current practice of routine admission and repeated scanning might be more intensive than necessary. The study concludes that larger, multi-center studies are needed to confirm these results, but the evidence gathered here points toward a more conservative approach that could spare many patients from unnecessary hospital stays.